Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 15 | 2018 | 322 | 3.190 |
Why?
|
| Musculoskeletal Diseases | 4 | 2019 | 34 | 2.040 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2020 | 127 | 1.880 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2023 | 3362 | 1.740 |
Why?
|
| Glomus Tumor | 2 | 2022 | 8 | 1.620 |
Why?
|
| Diagnostic Imaging | 4 | 2018 | 469 | 1.550 |
Why?
|
| Neurofibroma | 2 | 2022 | 11 | 0.960 |
Why?
|
| Fibula | 3 | 2018 | 32 | 0.960 |
Why?
|
| Neurilemmoma | 2 | 2022 | 34 | 0.940 |
Why?
|
| Radiography | 12 | 2020 | 813 | 0.900 |
Why?
|
| Femur | 4 | 2015 | 116 | 0.870 |
Why?
|
| Diagnosis, Differential | 13 | 2020 | 1565 | 0.830 |
Why?
|
| Tibia | 3 | 2015 | 82 | 0.830 |
Why?
|
| Sarcoma | 4 | 2015 | 215 | 0.810 |
Why?
|
| Sarcoma, Synovial | 2 | 2020 | 21 | 0.790 |
Why?
|
| Lipoma | 2 | 2020 | 25 | 0.780 |
Why?
|
| Fibroma | 2 | 2020 | 33 | 0.780 |
Why?
|
| Joint Diseases | 3 | 2014 | 49 | 0.780 |
Why?
|
| Giant Cell Tumor of Tendon Sheath | 1 | 2020 | 2 | 0.740 |
Why?
|
| Tarsal Bones | 2 | 2023 | 9 | 0.710 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 71 | 0.680 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 33 | 0.680 |
Why?
|
| Audiovisual Aids | 1 | 2017 | 7 | 0.610 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 111 | 0.600 |
Why?
|
| Image Enhancement | 2 | 2013 | 563 | 0.590 |
Why?
|
| Femoral Neoplasms | 2 | 2014 | 24 | 0.560 |
Why?
|
| Knee Joint | 4 | 2014 | 168 | 0.550 |
Why?
|
| Giant Cell Tumor of Bone | 3 | 2004 | 14 | 0.550 |
Why?
|
| Teaching | 1 | 2017 | 147 | 0.550 |
Why?
|
| Infarction | 1 | 2015 | 26 | 0.540 |
Why?
|
| Finger Phalanges | 1 | 2015 | 4 | 0.540 |
Why?
|
| Metacarpal Bones | 1 | 2015 | 10 | 0.530 |
Why?
|
| Musculoskeletal System | 1 | 2015 | 14 | 0.520 |
Why?
|
| Osteoma | 1 | 2014 | 5 | 0.520 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 110 | 0.510 |
Why?
|
| Radiology | 1 | 2017 | 194 | 0.500 |
Why?
|
| Patella | 1 | 2014 | 32 | 0.490 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 16 | 0.490 |
Why?
|
| Knee Injuries | 1 | 2014 | 53 | 0.480 |
Why?
|
| Hand Injuries | 1 | 2013 | 17 | 0.450 |
Why?
|
| Software | 1 | 2017 | 654 | 0.450 |
Why?
|
| Humans | 39 | 2023 | 86643 | 0.430 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 36 | 0.430 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 231 | 0.420 |
Why?
|
| Artifacts | 2 | 2019 | 244 | 0.420 |
Why?
|
| Bone Marrow Diseases | 1 | 2011 | 40 | 0.410 |
Why?
|
| Athletic Injuries | 1 | 2013 | 91 | 0.410 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 26 | 0.410 |
Why?
|
| Bone Diseases | 2 | 2011 | 54 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2018 | 2601 | 0.350 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2207 | 0.330 |
Why?
|
| Forearm | 1 | 2007 | 32 | 0.300 |
Why?
|
| Osteonecrosis | 3 | 2015 | 21 | 0.290 |
Why?
|
| Leg | 1 | 2007 | 137 | 0.290 |
Why?
|
| Connective Tissue Diseases | 1 | 2007 | 67 | 0.280 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 160 | 0.270 |
Why?
|
| Adult | 15 | 2023 | 25648 | 0.260 |
Why?
|
| Adolescent | 10 | 2013 | 8981 | 0.260 |
Why?
|
| Bone Diseases, Developmental | 1 | 2004 | 11 | 0.250 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 50 | 0.250 |
Why?
|
| Sacrum | 1 | 2004 | 40 | 0.250 |
Why?
|
| Male | 17 | 2023 | 40965 | 0.250 |
Why?
|
| Referral and Consultation | 1 | 2007 | 328 | 0.240 |
Why?
|
| Synovial Cyst | 2 | 2020 | 8 | 0.240 |
Why?
|
| Cysts | 1 | 2004 | 104 | 0.230 |
Why?
|
| Female | 19 | 2023 | 44532 | 0.230 |
Why?
|
| Shoulder Joint | 1 | 2004 | 90 | 0.230 |
Why?
|
| Neurofibromatoses | 1 | 2022 | 9 | 0.220 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2022 | 17 | 0.220 |
Why?
|
| Fingers | 1 | 2022 | 68 | 0.210 |
Why?
|
| Lower Extremity | 1 | 2022 | 84 | 0.210 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 252 | 0.210 |
Why?
|
| Middle Aged | 10 | 2015 | 25028 | 0.190 |
Why?
|
| Scapula | 1 | 2000 | 23 | 0.190 |
Why?
|
| Epidermal Cyst | 1 | 2020 | 7 | 0.190 |
Why?
|
| Ganglion Cysts | 1 | 2020 | 4 | 0.180 |
Why?
|
| Fasciitis | 1 | 2020 | 10 | 0.180 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.180 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 41 | 0.180 |
Why?
|
| Periostitis | 1 | 2018 | 4 | 0.170 |
Why?
|
| Voriconazole | 1 | 2018 | 17 | 0.170 |
Why?
|
| Hand | 1 | 2020 | 130 | 0.170 |
Why?
|
| Muscular Diseases | 2 | 2011 | 63 | 0.170 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 111 | 0.160 |
Why?
|
| Prosthesis Design | 1 | 2019 | 278 | 0.160 |
Why?
|
| Antifungal Agents | 1 | 2018 | 117 | 0.160 |
Why?
|
| Child | 7 | 2012 | 6927 | 0.160 |
Why?
|
| Osteomyelitis | 2 | 2011 | 54 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2020 | 695 | 0.150 |
Why?
|
| Computer Graphics | 1 | 2017 | 100 | 0.150 |
Why?
|
| Reoperation | 1 | 2019 | 597 | 0.140 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 220 | 0.130 |
Why?
|
| Patient Positioning | 1 | 2013 | 63 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2011 | 1939 | 0.110 |
Why?
|
| Curettage | 1 | 2011 | 12 | 0.100 |
Why?
|
| Argon Plasma Coagulation | 1 | 2011 | 6 | 0.100 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2011 | 7 | 0.100 |
Why?
|
| Fractures, Stress | 1 | 2011 | 10 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 12 | 0.100 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2011 | 23 | 0.100 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 67 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2011 | 71 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2023 | 8489 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2011 | 121 | 0.090 |
Why?
|
| Catheter Ablation | 2 | 2011 | 233 | 0.090 |
Why?
|
| Eosinophilic Granuloma | 1 | 2008 | 10 | 0.080 |
Why?
|
| Ileum | 1 | 2008 | 159 | 0.080 |
Why?
|
| Pain Clinics | 1 | 2007 | 2 | 0.080 |
Why?
|
| Oncology Service, Hospital | 1 | 2007 | 6 | 0.080 |
Why?
|
| Osteosarcoma | 2 | 2004 | 158 | 0.070 |
Why?
|
| Endometriosis | 1 | 2005 | 58 | 0.070 |
Why?
|
| Orthopedics | 1 | 2007 | 124 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6509 | 0.060 |
Why?
|
| Aged | 3 | 2015 | 18415 | 0.060 |
Why?
|
| Hemangioma, Cavernous | 1 | 2004 | 69 | 0.060 |
Why?
|
| Edema | 1 | 2023 | 71 | 0.060 |
Why?
|
| Young Adult | 2 | 2012 | 5976 | 0.060 |
Why?
|
| Radius | 1 | 2003 | 29 | 0.060 |
Why?
|
| Histiocytosis, Sinus | 1 | 2003 | 14 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2022 | 36 | 0.060 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2002 | 3 | 0.050 |
Why?
|
| Chondroblastoma | 1 | 2002 | 5 | 0.050 |
Why?
|
| Osteoma, Osteoid | 1 | 2002 | 9 | 0.050 |
Why?
|
| Osteochondroma | 1 | 2002 | 7 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 3640 | 0.050 |
Why?
|
| Bursitis | 1 | 2002 | 11 | 0.050 |
Why?
|
| Biopsy | 3 | 2011 | 1163 | 0.050 |
Why?
|
| Hematoma | 1 | 2002 | 104 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2705 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 383 | 0.040 |
Why?
|
| Thigh | 2 | 2005 | 38 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 1204 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 4213 | 0.030 |
Why?
|
| Infant | 1 | 2000 | 3046 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 1673 | 0.030 |
Why?
|
| Arm Bones | 1 | 2011 | 2 | 0.030 |
Why?
|
| Leg Bones | 1 | 2011 | 7 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 182 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 860 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1686 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 7993 | 0.020 |
Why?
|
| Prognosis | 2 | 2004 | 3679 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1801 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 2767 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 150 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 38 | 0.020 |
Why?
|
| Neurofibrosarcoma | 1 | 2003 | 3 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2261 | 0.010 |
Why?
|
| Ameloblastoma | 1 | 2003 | 7 | 0.010 |
Why?
|
| Hemangioendothelioma | 1 | 2003 | 9 | 0.010 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2003 | 25 | 0.010 |
Why?
|
| Chordoma | 1 | 2003 | 19 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 2003 | 48 | 0.010 |
Why?
|
| Sarcoma, Ewing | 1 | 2003 | 42 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 130 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5210 | 0.010 |
Why?
|
| Calcinosis | 1 | 2004 | 224 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 912 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 859 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1538 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 1056 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 3612 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1991 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 5417 | 0.010 |
Why?
|